Roberta Camisa

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patients.

Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 17, 2025

Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.

Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.

Journal: Cancer immunology, immunotherapy : CII

Published: June 13, 2023

Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity.

Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity.

Journal: Exploration of targeted anti-tumor therapy

Published: February 27, 2023

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer.

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: March 21, 2022

Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.

Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.

Journal: Immunotherapy

Published: September 16, 2020

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 27, 2020

Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals.

Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals.

Journal: Acta bio-medica : Atenei Parmensis

Published: May 07, 2020

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 12, 2020

Enteral Administration of TKIs: Report of a Response to Ceritinib in an ALK-positive NSCLC Patient and Literature Review.

Enteral Administration of TKIs: Report of a Response to Ceritinib in an ALK-positive NSCLC Patient and Literature Review.

Journal: Current drug targets

Published: July 10, 2017

Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).

Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 02, 2016

Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.

Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.

Journal: Acta bio-medica : Atenei Parmensis

Published: September 23, 2015

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 29, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026